Financhill
Back

Palvella Therapeutics, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
15

PVLA
Palvella Therapeutics, Inc.

Last Price:
$100.96
Seasonality Move:
132.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Palvella Therapeutics, Inc. Stock Forecast

  • Is Palvella Therapeutics, Inc. Stock Undervalued?
    The current Palvella Therapeutics, Inc. [PVLA] share price is $101.15. The Score for PVLA is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • PVLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Palvella Therapeutics, Inc. Stock Go Up Next Year?

Data Unavailable

Palvella Therapeutics, Inc. Stock Rating

Data Unavailable

Palvella Therapeutics, Inc. Stock Price History

Is PVLA stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PVLA is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
stock
Website:
palvellatx.com

52-Week Data

52-Week High:
114.69
52-Week Low:
11.17

Prediction Charts

Market Cap:
1.2B
Price in USD:
101.15
Volume:
175K
Beta:
-3.25

Technical Analysis

SMA50:
88.21
SMA100:
72.79
SMA200:
49.49
52-Wk Change:
742.88%

Stock Predictions

  • Is Palvella Therapeutics, Inc. stock public?
    Yes, Palvella Therapeutics, Inc. is a publicly traded company.
  • What is the Palvella Therapeutics, Inc. stock quote today?
    The Palvella Therapeutics, Inc. stock price is 101.15 USD today.
  • How to buy Palvella Therapeutics, Inc. stock online?
    You can buy Palvella Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-9 101.50 98.99 103.00 96.55
Dec-10 98.14 97.43 99.50 95.78
Dec-11 97.38 96.78 100.00 95.28
Dec-12 97.81 98.58 99.40 95.86
Dec-15 109.66 88.98 112.00 84.25
Dec-16 90.01 96.81 98.75 89.24
Dec-17 96.82 92.01 97.25 90.42
Dec-18 92.31 96.24 96.86 92.20
Dec-19 96.79 99.73 102.45 95.91
Dec-22 99.73 109.07 114.69 99.02
Dec-23 110.00 100.27 111.68 99.00
Dec-24 101.29 105.83 108.02 101.29
Dec-26 105.50 103.37 107.50 101.02
Dec-29 102.93 101.15 103.40 99.18

Palvella Therapeutics, Inc. Earnings

Data Unavailable

Palvella Therapeutics, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.53 per share.

* Palvella Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.